Stocks and Investing Stocks and Investing
Thu, June 22, 2023
Wed, June 21, 2023
Tue, June 20, 2023
Mon, June 19, 2023
Fri, June 16, 2023

John Newman Reiterated (ALLO) at Strong Buy and Held Target at $35 on, Jun 16th, 2023


Published on 2024-10-28 04:23:31 - WOPRAI, John Newman
  Print publication without navigation


John Newman of Canaccord Genuity, Reiterated "Allogene Therapeutics, Inc." (ALLO) at Strong Buy and Held Target at $35 on, Jun 16th, 2023.

John has made no other calls on ALLO in the last 4 months.



There are 9 other peers that have a rating on ALLO. Out of the 9 peers that are also analyzing ALLO, 3 agree with John's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Benjamin Burnett of "Stifel" Maintained at Hold with Decreased Target to $7.5 on, Thursday, May 4th, 2023
  • William Pickering of "Bernstein" Initiated at Hold and Held Target at $6 on, Tuesday, March 21st, 2023
  • Benjamin Chaiken of "JMP Securities" Maintained at Hold with Decreased Target to $19 on, Thursday, March 2nd, 2023


These are the ratings of the 6 analyists that currently disagree with John


  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $15 on, Monday, June 5th, 2023
  • Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $15 on, Monday, June 5th, 2023
  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $23 on, Friday, May 5th, 2023
  • Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $15 on, Thursday, May 4th, 2023
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $31 on, Thursday, March 2nd, 2023
  • Mark Breidenbach of "Oppenheimer" Maintained at Buy with Decreased Target to $28 on, Wednesday, March 1st, 2023